Who owns the ADTHYZA (THYROID TABLETS, USP) trademark?

The ADTHYZA (THYROID TABLETS, USP) trademark is owned by Azurity Pharmaceuticals, Inc..

What class is the ADTHYZA (THYROID TABLETS, USP) trademark registered in?

The ADTHYZA (THYROID TABLETS, USP) trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for ADTHYZA (THYROID TABLETS, USP)?

The USPTO serial number for ADTHYZA (THYROID TABLETS, USP) is 97538981.

What is the registration number for ADTHYZA (THYROID TABLETS, USP)?

ADTHYZA (THYROID TABLETS, USP) is registered under USPTO registration number 7116955.

ADT

USPTO Trademark Record

REGISTERED

ADTHYZA (THYROID TABLETS, USP)

SN 97538981·Reg 7116955·Filed Aug 08, 2022

Owner Azurity Pharmaceuticals, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

ADTHYZA (THYROID TABLETS, USP) (Serial No. 97538981), Registration No. 7116955, is a registered US trademark filed on Aug 08, 2022 by Azurity Pharmaceuticals, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: July 18, 2029

Mark Intelligence

ADTHYZA (THYROID TABLETS, USP) (Reg. #7116955) is a registered US trademark that has been protecting its owner, Azurity Pharmaceuticals, Inc., since 2022. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Aug 08, 2022

SERIAL

97538981

REG#

7116955

REGISTERED

Jul 18, 2023

Owner

Applicant

Azurity Pharmaceuticals, Inc.

Entity

Corporation

State

Address

8 Cabot Road, Suite 2000, Woburn, MA, 01801

Country

Attorney

NameElizabeth Fox

Law firm

Elizabeth Fox KING & SPALDING

Address

1180 PEACHTREE STREET, ATLANTA, GA 30309, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateAug 08, 2022

Serial Number97538981

Registration No.7116955

Registration DateJul 18, 2023

Status DateJul 18, 2023

Published for OppositionFeb 14, 2023

Mark TypeDesign with words

Status DescriptionLive and registered

Filing Signals

FILED

2022

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Feb 21, 2023

First use in commerce: Feb 21, 2023

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

18 events

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Mar 19, 2025

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

REGISTERED-PRINCIPAL REGISTER

Jul 18, 2023

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jul 18, 2023

NOTICE OF REGISTRATION CONFIRMATION EMAILED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jun 16, 2023

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jun 15, 2023

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

STATEMENT OF USE PROCESSING COMPLETE

May 23, 2023

STATEMENT OF USE PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

May 22, 2023

CASE ASSIGNED TO INTENT TO USE PARALEGAL

TEAS STATEMENT OF USE RECEIVED

May 01, 2023

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

May 01, 2023

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Apr 11, 2023

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Feb 14, 2023

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Feb 14, 2023

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jan 25, 2023

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 11, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Jan 10, 2023

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE E-MAILED

Aug 30, 2022

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Aug 28, 2022

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Aug 11, 2022

NEW APPLICATION ENTERED

ADTHYZA (THYROID TABLETS, USP)

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Azurity Pharmaceuticals, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Elizabeth Fox

Resources

Company